# SYNTAXISBIO MASTER SERVICES AGREEMENT

**IMPORTANT LEGAL NOTICE: This is a template document for review and customization by qualified legal counsel. Do not use without attorney review and modification for your specific business needs and jurisdiction.**

---

## MASTER SERVICES AGREEMENT

This Master Services Agreement ("Agreement") is entered into as of \_\_\_\_\_\_\_\_\_\_ ("Effective Date") by and between:

**SyntaxisBio** ("Provider")
[Address]
[City, State ZIP]
Email: info@syntaxisbio.com

and

**[Client Name]** ("Client")
[Address]
[City, State ZIP]
Email: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

Provider and Client are collectively referred to as the "Parties" and individually as a "Party."

---

## 1. SCOPE OF SERVICES

1.1 **Services Described.** Provider agrees to perform cell line engineering services as specified in individual Service Orders executed under this Agreement. Services may include but are not limited to:
   - CRISPR-based gene editing (knockout, knock-in, or other modifications)
   - Clonal cell line selection and validation
   - Genetic Physical Unclonable Function (PUF) authentication integration
   - Cell line authentication and identity verification
   - Age tracking implementation
   - Quality control and validation testing

1.2 **Service Orders.** Each project shall be documented in a Service Order that references this Agreement and specifies:
   - Detailed scope of work and deliverables
   - Timeline and milestones
   - Pricing and payment terms
   - Any special terms specific to that project

1.3 **Client Responsibilities.** Client shall:
   - Provide starting materials (cell lines, plasmids, etc.) in good condition
   - Provide accurate information about starting materials
   - Respond to Provider requests for clarification within 5 business days
   - Ensure all necessary institutional approvals are obtained
   - Warrant that Client has rights to use all provided materials

---

## 2. DELIVERABLES

2.1 **Standard Deliverables.** Unless otherwise specified in the Service Order, Provider shall deliver:
   - Modified cell line(s) in specified quantity (typically 2-4 vials)
   - Certificate of Analysis documenting validation results
   - Sequencing data confirming genetic modifications
   - STR authentication results
   - PUF authentication data (if applicable)

2.2 **Acceptance.** Client shall inspect deliverables within 10 business days of receipt and notify Provider of any non-conformance with specifications. Deliverables shall be deemed accepted if Client does not provide written notice of rejection within this period.

2.3 **Claims Period.** Any claims regarding cell viability, contamination, or non-conformance with specifications must be submitted within 30 days of delivery. Claims submitted after this period will not be accepted.

---

## 3. TIMELINE AND DELAYS

3.1 **Estimated Timeline.** Timelines provided in Service Orders are estimates based on typical project progression. Actual timelines may vary due to biological factors beyond Provider's control.

3.2 **Delays Beyond Provider's Control.** Provider shall not be liable for delays caused by:
   - Poor quality or viability of Client-provided starting materials
   - Biological variability in cell line response to modifications
   - Client delays in responding to questions or providing approvals
   - Force majeure events (natural disasters, pandemics, government actions, etc.)

3.3 **Communication.** Provider shall provide regular project updates at reasonable intervals and notify Client promptly of any significant delays or technical challenges.

---

## 4. PAYMENT TERMS

4.1 **Pricing.** Fees for services shall be specified in each Service Order.

4.2 **Payment Structure.**
   - **Deposit:** 50% of project fee due upon execution of Service Order
   - **Final Payment:** 50% due upon completion before delivery of materials
   - **Expenses:** Reasonable out-of-pocket expenses shall be billed at cost plus 10%

4.3 **Late Payment.** Payments not received within 30 days of invoice date shall accrue interest at 1.5% per month or the maximum rate permitted by law, whichever is less.

4.4 **Withholding Delivery.** Provider may withhold delivery of materials and data until all payments are received in full.

---

## 5. INTELLECTUAL PROPERTY

5.1 **Client IP.** Client retains all ownership rights to:
   - Starting materials provided to Provider
   - Modified cell lines created under this Agreement
   - Client's proprietary information disclosed to Provider

5.2 **Provider IP.** Provider retains all ownership rights to:
   - Genetic PUF technology and methodologies
   - Provider's protocols, processes, and know-how
   - Provider's proprietary information and trade secrets

5.3 **License Grant.** Provider grants Client a non-exclusive, perpetual license to use delivered cell lines for Client's internal research purposes. This license does not include rights to:
   - Reverse engineer or analyze Provider's PUF technology
   - Distribute or sell modified cell lines to third parties without written agreement
   - Use Provider's methodologies to create similar services

5.4 **Publications.** Client may publish research results obtained using delivered cell lines. Client agrees to acknowledge Provider in publications as follows: "Cell lines were engineered by SyntaxisBio (syntaxisbio.com) using genetic PUF authentication technology."

---

## 6. CONFIDENTIALITY

6.1 **Confidential Information.** Each Party agrees to maintain in confidence all proprietary information disclosed by the other Party, including but not limited to technical data, research plans, and business information.

6.2 **Exclusions.** Confidential information does not include information that:
   - Was publicly known prior to disclosure
   - Becomes publicly known through no breach by receiving Party
   - Was rightfully known by receiving Party prior to disclosure
   - Is independently developed by receiving Party without use of confidential information
   - Is required to be disclosed by law or court order (with prior notice to disclosing Party)

6.3 **Term.** Confidentiality obligations shall survive for 5 years after termination of this Agreement.

---

## 7. WARRANTIES AND DISCLAIMERS

7.1 **Provider Warranties.** Provider warrants that:
   - Delivered cell lines shall conform to specifications stated in Service Order at time of delivery
   - Services shall be performed in a professional and workmanlike manner
   - Deliverables shall be free from mycoplasma contamination at time of shipment
   - Genetic modifications shall be confirmed by sequencing before delivery

7.2 **WARRANTY LIMITATIONS.**
   - Warranties apply only to condition of deliverables at time of shipment
   - Cell viability and performance after receipt are affected by shipping, handling, and culture conditions beyond Provider's control
   - Provider does not warrant continued viability after delivery

7.3 **DISCLAIMER OF IMPLIED WARRANTIES.** EXCEPT AS EXPRESSLY STATED IN SECTION 7.1, PROVIDER MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. PROVIDER DOES NOT WARRANT THAT DELIVERED CELL LINES WILL BE SUITABLE FOR CLIENT'S INTENDED APPLICATIONS OR WILL PRODUCE DESIRED RESEARCH OUTCOMES.

7.4 **Research Use Only.** Unless otherwise specified in writing, all cell lines are provided for research use only and are not intended for diagnostic, therapeutic, or commercial purposes.

---

## 8. LIMITATION OF LIABILITY

8.1 **LIABILITY CAP.** Provider's total cumulative liability arising out of or related to this Agreement shall not exceed the amount of fees paid by Client under the applicable Service Order giving rise to the claim.

8.2 **EXCLUSION OF CONSEQUENTIAL DAMAGES.** IN NO EVENT SHALL PROVIDER BE LIABLE FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION:
   - Lost profits or revenue
   - Loss of data or research results
   - Cost of substitute services
   - Wasted research time or materials
   - Damage to reputation

This exclusion applies even if Provider has been advised of the possibility of such damages and regardless of the legal theory (contract, tort, negligence, strict liability, or otherwise).

8.3 **Exceptions.** The limitations in this Section 8 do not apply to:
   - Claims arising from Provider's gross negligence or willful misconduct
   - Provider's indemnification obligations under Section 9
   - Violations of the other Party's intellectual property rights

---

## 9. INDEMNIFICATION

9.1 **Client Indemnification.** Client shall indemnify, defend, and hold harmless Provider from any claims, damages, or expenses arising from:
   - Client's breach of warranties regarding ownership or rights to use starting materials
   - Third-party claims that Client-provided materials infringe intellectual property rights
   - Client's use of deliverables in violation of this Agreement
   - Any injury or harm caused by Client's use of deliverables

9.2 **Provider Indemnification.** Provider shall indemnify, defend, and hold harmless Client from any claims, damages, or expenses arising from:
   - Provider's gross negligence or willful misconduct in performing services
   - Third-party claims that Provider's PUF technology infringes intellectual property rights
   - Provider's breach of confidentiality obligations

9.3 **Procedure.** The indemnified party shall provide prompt written notice of any claim and shall cooperate with the indemnifying party's defense. The indemnifying party shall have sole control of the defense and settlement.

---

## 10. BIOLOGICAL MATERIALS HANDLING

10.1 **Biosafety.** Client warrants that all materials provided to Provider are biosafety level 1 (BSL-1) or BSL-2 unless otherwise agreed in writing. Client shall disclose any known hazards.

10.2 **Regulatory Compliance.** Both Parties shall comply with all applicable laws and regulations governing handling, storage, and transport of biological materials.

10.3 **Disposal.** Provider reserves the right to dispose of Client materials 90 days after project completion unless other arrangements are agreed in writing.

---

## 11. TERM AND TERMINATION

11.1 **Term.** This Agreement shall commence on the Effective Date and continue until terminated by either Party.

11.2 **Termination for Convenience.** Either Party may terminate this Agreement with 30 days written notice. Termination does not affect Service Orders already in progress.

11.3 **Termination for Cause.** Either Party may terminate immediately upon written notice if the other Party:
   - Materially breaches this Agreement and fails to cure within 30 days of notice
   - Becomes insolvent or files for bankruptcy
   - Ceases business operations

11.4 **Effect of Termination.**
   - Client shall pay for all services performed and expenses incurred through termination date
   - Provider shall deliver all completed work products and Client materials
   - Sections 5, 6, 7, 8, 9, and 12 shall survive termination

---

## 12. GENERAL PROVISIONS

12.1 **Governing Law.** This Agreement shall be governed by the laws of [State], without regard to conflicts of law principles.

12.2 **Dispute Resolution.** Any disputes shall be resolved through:
   - First: Good faith negotiation between senior representatives
   - Second: Mediation conducted in [City, State]
   - Third: Binding arbitration under AAA Commercial Arbitration Rules

12.3 **Entire Agreement.** This Agreement and executed Service Orders constitute the entire agreement between Parties and supersede all prior agreements and understandings.

12.4 **Amendments.** Amendments must be in writing and signed by authorized representatives of both Parties.

12.5 **Assignment.** Neither Party may assign this Agreement without prior written consent of the other Party, except that Provider may assign to an affiliate or in connection with a merger or acquisition.

12.6 **Notices.** All notices shall be in writing and sent to addresses stated above or as subsequently updated in writing. Notices are effective upon receipt.

12.7 **Severability.** If any provision is found invalid or unenforceable, the remaining provisions shall continue in full force and effect.

12.8 **Waiver.** Failure to enforce any provision does not constitute a waiver of that or any other provision.

12.9 **Independent Contractors.** The Parties are independent contractors. Nothing in this Agreement creates an employment, agency, or partnership relationship.

---

## SIGNATURES

**PROVIDER: SyntaxisBio**

By: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Name: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Title: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Date: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

**CLIENT: [Client Name]**

By: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Name: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Title: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Date: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

---

**LEGAL DISCLAIMER:** This template is provided for informational purposes only and does not constitute legal advice. Before using this agreement, you must have it reviewed and customized by a licensed attorney familiar with your business, jurisdiction, and specific circumstances. Laws vary by state and country, and this template may not address all legal requirements or protect all of your interests.
